multiple myeloma, and melanoma. However, T-cell therapy still faces several limitations, including off-target effects, tumour antigen escape, and the immunosuppressive tumor microenvironment. Serious adverse reactions…
blood disorders, anemias, bleeding disorders, and transfusion medicine. It emphasizes the evolving roles of targeted therapies and immunotherapies in pediatric leukemias and lymphomas, and the potential of gene editing
Targeted therapies are transforming endometrial cancer treatment by addressing specific molecular alterations. This includes inhibitors targeting PI3K/AKT/mTOR, HER2, and DNA damage repair pathways, showing promise for…
Endometrial cancer treatment is advancing with targeted therapies and immunotherapies addressing resistance. Key strategies involve targeting PI3K, HER2, and DNA mismatch repair deficiencies. Pembrolizumab demonstrates…
pain by sensitizing nociceptors and modulating neuronal excitability. The studies underscore the significance of targeting these pathways for effective pain management and discuss existing and emerging therapeutic…